Estonia is the first country to receive the potential COVID-19 medication Avigan from Japan for research
COVID-19: A cautious attitude toward “ivermectin”: Central Epidemic Headquarters
COVID-19: Kitasato Univ., To ivermectin clinical trial: antiparasitic drug, new corona